Caitong International Asset Management’s Valion Bio VBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding VBIO
Caitong International Asset Management's VBIO Position: Q2 2026 in Review
Caitong International Asset Management held its Valion Bio (VBIO) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #2921.
Caitong International Asset Management first reported a position in VBIO in Q1 2026 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold VBIO as of Q2 2026.
- Caitong International Asset Management held 1 share of Valion Bio worth $1 as of Q2 2026.
- Caitong International Asset Management left its Valion Bio share count unchanged in Q2 2026.
- Valion Bio made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2921 holding.
- Caitong International Asset Management first reported a position in Valion Bio in Q1 2026 and has held it in 2 quarters since.
- 3 funds tracked by Wall St. Rank held Valion Bio as of Q2 2026.
Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.